US Stock MarketDetailed Quotes

OMGA Omega Therapeutics

Watchlist
  • 2.070
  • -0.085-3.94%
Trading May 8 15:23 ET
114.17MMarket Cap-1246P/E (TTM)

Omega Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
357.36%2.36M
49.25%3.09M
34.56%989K
39.66%831K
59.45%759K
92.54%516K
1,339.58%2.07M
410.42%735K
595K
476K
Operating revenue
357.36%2.36M
49.25%3.09M
34.56%989K
39.66%831K
59.45%759K
92.54%516K
1,339.58%2.07M
410.42%735K
--595K
--476K
Cost of revenue
Gross profit
Operating expense
-13.38%22.81M
-1.42%103.36M
-31.59%21.69M
-10.71%23.73M
20.01%31.6M
30.19%26.33M
58.42%104.84M
52.35%31.7M
54.35%26.58M
73.17%26.33M
Selling and administrative expenses
18.47%7.4M
10.62%26.19M
-14.57%6.16M
51.39%7.87M
0.06%6.21M
15.48%6.24M
42.58%23.67M
26.60%7.21M
16.57%5.2M
70.53%6.2M
-General and administrative expense
18.47%7.4M
10.62%26.19M
-14.57%6.16M
51.39%7.87M
0.06%6.21M
15.48%6.24M
42.58%23.67M
26.60%7.21M
16.57%5.2M
70.53%6.2M
Research and development costs
-23.27%15.42M
-4.93%77.17M
-41.44%15.72M
-20.30%16.48M
29.01%25.01M
41.58%20.09M
69.57%81.17M
83.28%26.84M
68.20%20.67M
73.35%19.39M
Other operating expenses
----
----
----
-185.67%-610K
-48.58%381K
----
----
----
50.53%712K
92.97%741K
Operating profit
20.79%-20.45M
2.44%-100.26M
33.16%-20.7M
11.86%-22.9M
-19.29%-30.84M
-29.36%-25.82M
-55.63%-102.77M
-49.86%-30.97M
-50.89%-25.99M
-70.04%-25.85M
Net non-operating interest income expense
-51.47%331K
1,165.77%2.81M
96.37%487K
271.74%684K
1,840.00%957K
540.00%682K
124.40%222K
246.75%248K
154.28%184K
71.05%-55K
Non-operating interest income
-51.47%331K
1,165.77%2.81M
----
----
----
--682K
--222K
----
----
----
Total other finance cost
----
----
----
-271.74%-684K
-1,840.00%-957K
----
----
----
-154.28%-184K
--55K
Other net income (expense)
93.71%-9K
114.65%23K
98.13%-2K
-1,550.00%-29K
6,633.33%196K
-186.00%-143K
88.27%-157K
-409.52%-107K
100.21%2K
80.00%-3K
Other non- operating income (expenses)
93.71%-9K
114.65%23K
98.13%-2K
-1,550.00%-29K
6,633.33%196K
-186.00%-143K
-460.71%-157K
-409.52%-107K
0.00%2K
25.00%-3K
Income before tax
20.37%-20.13M
5.13%-97.43M
34.43%-20.21M
13.76%-22.25M
-14.57%-29.69M
-25.37%-25.28M
-50.41%-102.7M
-47.82%-30.83M
-39.24%-25.8M
-68.15%-25.91M
Income tax
Net income
20.37%-20.13M
5.13%-97.43M
34.43%-20.21M
13.76%-22.25M
-14.57%-29.69M
-25.37%-25.28M
-50.41%-102.7M
-47.82%-30.83M
-39.24%-25.8M
-68.15%-25.91M
Net income continuous Operations
20.37%-20.13M
5.13%-97.43M
34.43%-20.21M
13.76%-22.25M
-14.57%-29.69M
-25.37%-25.28M
-50.41%-102.7M
-47.82%-30.83M
-39.24%-25.8M
-68.15%-25.91M
Minority interest income
Net income attributable to the parent company
20.37%-20.13M
5.13%-97.43M
34.43%-20.21M
13.76%-22.25M
-14.57%-29.69M
-25.37%-25.28M
-50.41%-102.7M
-47.82%-30.83M
-39.24%-25.8M
-68.15%-25.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
20.37%-20.13M
5.13%-97.43M
34.43%-20.21M
13.76%-22.25M
-14.57%-29.69M
-25.37%-25.28M
-50.41%-102.7M
-47.82%-30.83M
-39.24%-25.8M
-68.15%-25.91M
Basic earnings per share
28.00%-0.36
15.89%-1.8
43.75%-0.36
25.93%-0.4
0.00%-0.54
-19.05%-0.5
29.84%-2.14
-45.45%-0.64
5.26%-0.54
-63.74%-0.54
Diluted earnings per share
28.00%-0.36
15.89%-1.8
43.75%-0.36
25.93%-0.4
0.00%-0.54
-19.05%-0.5
29.84%-2.14
-45.45%-0.64
5.26%-0.54
-63.74%-0.54
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 357.36%2.36M49.25%3.09M34.56%989K39.66%831K59.45%759K92.54%516K1,339.58%2.07M410.42%735K595K476K
Operating revenue 357.36%2.36M49.25%3.09M34.56%989K39.66%831K59.45%759K92.54%516K1,339.58%2.07M410.42%735K--595K--476K
Cost of revenue
Gross profit
Operating expense -13.38%22.81M-1.42%103.36M-31.59%21.69M-10.71%23.73M20.01%31.6M30.19%26.33M58.42%104.84M52.35%31.7M54.35%26.58M73.17%26.33M
Selling and administrative expenses 18.47%7.4M10.62%26.19M-14.57%6.16M51.39%7.87M0.06%6.21M15.48%6.24M42.58%23.67M26.60%7.21M16.57%5.2M70.53%6.2M
-General and administrative expense 18.47%7.4M10.62%26.19M-14.57%6.16M51.39%7.87M0.06%6.21M15.48%6.24M42.58%23.67M26.60%7.21M16.57%5.2M70.53%6.2M
Research and development costs -23.27%15.42M-4.93%77.17M-41.44%15.72M-20.30%16.48M29.01%25.01M41.58%20.09M69.57%81.17M83.28%26.84M68.20%20.67M73.35%19.39M
Other operating expenses -------------185.67%-610K-48.58%381K------------50.53%712K92.97%741K
Operating profit 20.79%-20.45M2.44%-100.26M33.16%-20.7M11.86%-22.9M-19.29%-30.84M-29.36%-25.82M-55.63%-102.77M-49.86%-30.97M-50.89%-25.99M-70.04%-25.85M
Net non-operating interest income expense -51.47%331K1,165.77%2.81M96.37%487K271.74%684K1,840.00%957K540.00%682K124.40%222K246.75%248K154.28%184K71.05%-55K
Non-operating interest income -51.47%331K1,165.77%2.81M--------------682K--222K------------
Total other finance cost -------------271.74%-684K-1,840.00%-957K-------------154.28%-184K--55K
Other net income (expense) 93.71%-9K114.65%23K98.13%-2K-1,550.00%-29K6,633.33%196K-186.00%-143K88.27%-157K-409.52%-107K100.21%2K80.00%-3K
Other non- operating income (expenses) 93.71%-9K114.65%23K98.13%-2K-1,550.00%-29K6,633.33%196K-186.00%-143K-460.71%-157K-409.52%-107K0.00%2K25.00%-3K
Income before tax 20.37%-20.13M5.13%-97.43M34.43%-20.21M13.76%-22.25M-14.57%-29.69M-25.37%-25.28M-50.41%-102.7M-47.82%-30.83M-39.24%-25.8M-68.15%-25.91M
Income tax
Net income 20.37%-20.13M5.13%-97.43M34.43%-20.21M13.76%-22.25M-14.57%-29.69M-25.37%-25.28M-50.41%-102.7M-47.82%-30.83M-39.24%-25.8M-68.15%-25.91M
Net income continuous Operations 20.37%-20.13M5.13%-97.43M34.43%-20.21M13.76%-22.25M-14.57%-29.69M-25.37%-25.28M-50.41%-102.7M-47.82%-30.83M-39.24%-25.8M-68.15%-25.91M
Minority interest income
Net income attributable to the parent company 20.37%-20.13M5.13%-97.43M34.43%-20.21M13.76%-22.25M-14.57%-29.69M-25.37%-25.28M-50.41%-102.7M-47.82%-30.83M-39.24%-25.8M-68.15%-25.91M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 20.37%-20.13M5.13%-97.43M34.43%-20.21M13.76%-22.25M-14.57%-29.69M-25.37%-25.28M-50.41%-102.7M-47.82%-30.83M-39.24%-25.8M-68.15%-25.91M
Basic earnings per share 28.00%-0.3615.89%-1.843.75%-0.3625.93%-0.40.00%-0.54-19.05%-0.529.84%-2.14-45.45%-0.645.26%-0.54-63.74%-0.54
Diluted earnings per share 28.00%-0.3615.89%-1.843.75%-0.3625.93%-0.40.00%-0.54-19.05%-0.529.84%-2.14-45.45%-0.645.26%-0.54-63.74%-0.54
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg